It can soothe the stomach lining and improve gut motility, reducing the incidence and severity of gastrointestinal distress
In comparison, the patients lost 17.5% of their body weight on average at 24 weeks and 24.2% of weight after 48 weeks in phase 2 clinical trials with retatrutide
10.1038/s42255-024-01068-x 79 RakipovskiG.RolinB.NohrJ.KleweI.FrederiksenK
Gross spending on Medicaid prescriptions for GLP-1s for diabetes as well as for weight loss has increased from around $1 billion in 2019 to almost $9 billion in 2024 as demand for these drugs has risen, according to KFF
Leah Joseph, MD, FACP , provides expert guidance to help you choose the best treatment for your needs
On 10 November, Novo announced plans to invest DKK42 billion (5 billion) to upgrade its manufacturing facilities to support GLP-1 products as well as other treatments for chronic diseases